» Articles » PMID: 39342205

Insulin Resistance Assessed by Estimated Glucose Disposal Rate and Risk of Atherosclerotic Cardiovascular Diseases Incidence: the Multi-ethnic Study of Atherosclerosis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To investigate the relationship between estimated glucose disposal rate (eGDR), a surrogate indicator of insulin resistance, and atherosclerotic cardiovascular diseases (ASCVD) incidence risk.

Methods: This prospective cohort study utilized data from the 6026 participants from the Multi-Ethnic Study of Atherosclerosis. The eGDR (mg/kg/min) was computed as 21.158 - (0.09 × waist circumference [cm]) - (3.407 × hypertension [yes/no]) - (0.551 × HbA1c [%]). The population was categorized into four subgroups according to the quartiles (Q) of eGDR. Cox proportional hazard models were applied to assess the associations between eGDR and ASCVD incidence, and restricted cubic spine (RCS) was employed to examine the dose-response relationship.

Results: The mean age of participants was 63.6 ± 10.1 years, comprising 3163 (52.5%) women. Over a median follow-up duration of 14.1 years, 565 (9.4%) developed ASCVD, including 256 (4.2%) myocardial infarctions, 234 (3.9%) strokes, and 358 (5.9%) fatal coronary heart disease. Compared to the lowest quartile, the adjusted hazard ratios (95% confidence intervals) for incident ASCVD for Q2-Q4 were 0.87 (0.68-1.10), 0.63 (0.47-0.84), and 0.43 (0.30-0.64), respectively. Per 1 standard deviation increase in eGDR was associated with a 30% (HR: 0.70, 95% CI 0.60-0.80) risk reduction of ASCVD, with the subgroup analyses indicating that age and hypertension modified the association (P for interaction < 0.05). RCS analysis indicated a significant and linear relationship between eGDR and ASCVD incidence risk.

Conclusion: eGDR level was negatively associated with incident ASCVD risk in a linear fashion among the general population. Our findings may contribute to preventive measures by improving ASCVD risk assessment.

Citing Articles

Association between estimated glucose disposal rate and prediction of cardiovascular disease risk among individuals with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study.

Tian J, Chen H, Luo Y, Zhang Z, Xiong S, Liu H Diabetol Metab Syndr. 2025; 17(1):58.

PMID: 39953554 PMC: 11827371. DOI: 10.1186/s13098-025-01626-7.


Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study.

Jiang L, Zhu T, Song W, Zhai Y, Tang Y, Ruan F Cardiovasc Diabetol. 2025; 24(1):56.

PMID: 39915878 PMC: 11804005. DOI: 10.1186/s12933-025-02618-7.


Correlation between estimated glucose disposal rate, insulin resistance, and cardiovascular mortality among individuals with metabolic syndrome: a population-based analysis, evidence from NHANES 1999-2018.

Xing D, Xu J, Weng X, Weng X Diabetol Metab Syndr. 2025; 17(1):11.

PMID: 39780246 PMC: 11714986. DOI: 10.1186/s13098-024-01574-8.


Kidney Damage in Pediatric Obesity: Insights from an Emerging Perspective.

Forcina G, Luciano M, Frattolillo V, Mori S, Monaco N, Guarino S J Clin Med. 2024; 13(23).

PMID: 39685484 PMC: 11642363. DOI: 10.3390/jcm13237025.


Association between estimated glucose disposal rate and female infertility: a cross-sectional study.

Li M, Zhang L, Li X, Yan W Front Endocrinol (Lausanne). 2024; 15:1474738.

PMID: 39600947 PMC: 11588443. DOI: 10.3389/fendo.2024.1474738.

References
1.
Garofolo M, Gualdani E, Scarale M, Bianchi C, Aragona M, Campi F . Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care. 2020; 43(10):e139-e141. PMC: 7510021. DOI: 10.2337/dc20-0433. View

2.
Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View

3.
Mozaffarian D . Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation. 2016; 133(2):187-225. PMC: 4814348. DOI: 10.1161/CIRCULATIONAHA.115.018585. View

4.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View

5.
Cersosimo E, DeFronzo R . Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006; 22(6):423-36. DOI: 10.1002/dmrr.634. View